Todd Usen - 11 Feb 2025 Form 4 Insider Report for Adagio Medical Holdings, Inc. (ADGM)

Role
Chief Executive Officer, Director
Signature
/s/ John Dahldorf, Attorney-in-Fact
Issuer symbol
ADGM
Transactions as of
11 Feb 2025
Net transactions value
$0
Form type
4
Filing time
13 Feb 2025, 14:29:18 UTC
Previous filing
20 Dec 2024
Next filing
15 Dec 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADGM Employee Stock Options (Right to Buy) Award $0 +1,820,567 $0.000000 1,820,567 11 Feb 2025 Common Stock 1,820,567 $1.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee Stock Options granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest over a four-year period, whereby twenty-five percent (25%) of the Option will vest on December 13, 2025, with the remaining shares subject to the Option vesting in thirty-six (36) equal monthly installments thereafter.